Akari Therapeutics, Plc (Nasdaq: AKTX ), an oncology biotechnology company pioneering next-generation antibody drug ...

ST. PETERSBURG, Fla., May 22, 2025 /PRNewswire/ -- Webull Corporation (NASDAQ: BULL) ("Webull" or the "Company") today announced financial results for the quarter ending March 31, 2025. "We are proud ...

(Bloomberg) -- Webull Financial is now offering futures and commodities trading as investors look for more ways to hedge price moves without owning an underlying asset. The online brokerage ...

Akari Therapeutics is an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs). The Company has developed its first novel payload, PH1, a spliceosome modulator ...

Online brokerage Webull Financial will pay $3 million in fines to settle charges that it didn’t perform the necessary due diligence when screening customers to be approved for options trading, ...

Financial literacy-focused nonprofit names Webull as official online broker and sponsor of the "Dollar-a-Day Challenge" ST. PETERSBURG, Fla., Nov. 7, 2025 /PRNewswire/ -- Webull (NASDAQ: BULL), an ...

Finding an online brokerage firm to use for your personal investment can be intimidating. There are many options out there, and it isn’t all about picking the option with the most bells and whistles — ...

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will ...

The unaudited financial and operational information included in this press release is subject to potential adjustments and is based on the information available to management at this time. Potential ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the Corporate Connect Webinar Series hosted by Webull Financial being held virtually ...